Treasury proposal would sharply limit US investments in much of China biotech
Draft regulations from the Treasury Department would put broad limits on what types of drug and biotech assets that US companies and venture capitalists could invest in and make deals for. The
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
